🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Recurrent miscarriage (RM) defined by \>=3 consecutive losses affects 1% of...
Status
Unknown
Location
Centre Hospitalier Annecy Genevois
Start Date
2017-12-04
Trial ID
NCT03165136
Treatments Being Tested
The primary objective of the study is to evaluate the efficacy of a booster...
Status
Enrolling By Invitation
Location
Cantonal Hospital Aarau
Start Date
2023-11-13
Trial ID
NCT06037564
Treatments Being Tested
The purpose of this study is to compare the efficacy and safety of venetocl...
Status
Completed
Location
Chinese PLA General Hospital
Start Date
2023-03-01
Trial ID
NCT06068621
This is a phase II, multi-arm, Bayesian adaptive platform trial designed to...
Status
Recruiting
Location
Zhongshan Hospital, Fudan University
Start Date
2026-01-19
Trial ID
NCT07328009
The primary objective of the study is to evaluate efficacy of entospletinib...
Status
Terminated
Location
University of Alabama at Birmingham
Start Date
2013-03-14
Trial ID
NCT01799889
Treatments Being Tested
This phase II trials studies how well pembrolizumab and vactosertib work af...
Status
Terminated
Location
University of California, San Francisco
Start Date
2019-07-22
Trial ID
NCT03844750
Treatments Being Tested
This is a phase 3 clinical study conducted in China. The primary objective ...
Status
Not Yet Recruiting
Location
China-Japan Friendship Hospital
Start Date
2026-08-31
Trial ID
NCT07719023
Treatments Being Tested
In this study, the efficacy and safety of two nilotinib doses, 300 mg twice...
Status
Completed
Location
University of California at Los Angeles Dept. of Hematology Clinic
Start Date
2007-07-31
Trial ID
NCT00471497
The purpose was to evaluate the efficacy and safety of the combination of c...
Status
Terminated
Location
Novartis Investigative Site
Start Date
2020-01-22
Trial ID
NCT04139317
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as hydroxychloroquine, carbopla...
Status
Terminated
Location
Cancer Institute of New Jersey at Hamilton
Start Date
2008-06-16
Trial ID
NCT00728845
Treatments Being Tested